HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garcia-Laverde, A. Articles by De Bonilla, L. Search for Related Content PubMed PubMed Citation Articles by Garcia-Laverde, A. Articles by De Bonilla, L.

Clinical Trials with Metronidazole in Human Balantidiasis

Therapeutic activity of metronidazole against Balantidium coli was evaluated by using two drug regimens in 20 human cases of balantidiasis. All patients also harbored Trichuris trichiura. Children received a total amount of drug that varied from 2.5 g during 5 days to 7.5 g in a period of 10 days. Adults were given 5 g in 5 days or 12.5 g during a period of 10 days. In all patients B. coli disappeared after the 4th day of treatment. Frequent posttreatment stool examinations remained negative. All patients tolerated the drug well and there were no side effects.

Accepted for publication January 20, 1975.

This article has been cited by other articles:

				A A Escobedo, P Almirall, M Alfonso, S Cimerman, S Rey, and S L Terry Treatment of intestinal protozoan infections in children Arch. Dis. Child., June 1, 2009; 94(6): 478 - 482. [Abstract] [Full Text] [PDF]

				F. L. Schuster and L. Ramirez-Avila Current World Status of Balantidium coli Clin. Microbiol. Rev., October 1, 2008; 21(4): 626 - 638. [Abstract] [Full Text] [PDF]